Brussels, 19 March 2025

EuropaBio supports the recognition of challenges faced by innovative biotech companies in accessing capital in the EU, as highlighted in the ‘’Savings and Investments Unions Communication’’.

In line with the submitted response to the Call for Evidence for the EU Startup and Scaleup Strategy, EuropaBio aligns with the Commission's urgency for accessible financing and capital for startups and scaleups, which will ultimately leverage their innovation to boost the EU’s economic competitiveness and security.

We, therefore, urge European institutions and Member States to take forward the savings and investment union to overcome financial fragmentation and retain the European startup ecosystem in the region.

Dr. Claire Skentelbery, Director General of EuropaBio said “Proper financing mechanisms are critical to advance biotech and biomanufacturing innovators to grow, invest and stay in Europe. The EU should increase support that can benefit biotech innovation from companies of all scales, to secure its autonomy and resilience.”

EuropaBio remains committed to engaging with stakeholders to support EU global competitiveness opportunities, making our industries stronger, greener and more innovative through biotech.